Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Innate immune pattern-recognition receptors (PRRs) are a diverse class of sensors responsible for detecting pathogen-associated molecular patterns (PAMPs), including exogenous nucleic acids delivered via lipid nanoparticles (LNPs). In the context of mRNA therapeutics like those utilizing the ARP02 sequence—a specific luciferase-encoding mRNA construct used in the development of Alnylam's LNP technology—these receptors, primarily Toll-like receptors (TLR7, TLR8) and RIG-I-like receptors (RIG-I, MDA5), recognize the mRNA's structural features and LNP components. This recognition triggers signaling cascades involving adapter proteins like MyD88 and MAVS, leading to the production of Type I interferons and pro-inflammatory cytokines. While this response is beneficial for vaccine adjuvancy, it represents a significant safety and efficacy hurdle for protein replacement therapies, as it can lead to infusion-related reactions and reduced translation of the therapeutic protein. Strategies to mitigate this sensing include the use of modified nucleosides (e.g., N1-methylpseudouridine) and optimized LNP formulations to minimize the activation of these innate immune pathways.
Activation of endosomal Toll-like receptors (TLR7/8) and cytoplasmic RIG-I-like receptors (RIG-I/MDA5) by mRNA-LNP complexes, leading to the induction of Type I interferons and pro-inflammatory cytokines via MyD88 and MAVS signaling pathways.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate immune pattern-recognition receptors (PRRs) (PRRs).